Advertisement
Document › Details
BioLineRx Ltd.. (8/6/19). "Press Release: BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". Tel Aviv.
Organisation | BioLineRx Ltd. (Nasdaq: BLRX, TASE: BLRX) | |
Group | BioLineRx (Group) | |
Organisation 2 | LifeSci Advisors LLC | |
Group | LifeSci (Group) | |
Product | BL-8040 (BioLineRx) | |
Product 2 | AGI-134 (Agalimmune) | |
Person | Serlin, Philip A. (BioLineRx 201610– CEO joined 2009 as CFO + COO before Kayote Networks + Tescom Software) | |
Original document
accessed by [iito] on 2019-08-06
Record changed: 2024-08-24 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top